Recent Clinical Developments of Nanomediated Drug Delivery Systems of Taxanes for the Treatment of Cancer

Ruben AG van Eerden,1 Ron HJ Mathijssen,1 Stijn LW Koolen1,2 1Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands; 2Department of Hospital Pharmacy, Erasmus MC University Medical Center, Rotterdam, the NetherlandsCorrespondence: Ruben AG van EerdenDepartment of Me...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: van Eerden RAG, Mathijssen RHJ, Koolen SLW
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2020
Materias:
Acceso en línea:https://doaj.org/article/da2b094e68184f01a02aca51e7ee3acb
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:da2b094e68184f01a02aca51e7ee3acb
record_format dspace
spelling oai:doaj.org-article:da2b094e68184f01a02aca51e7ee3acb2021-12-02T15:28:42ZRecent Clinical Developments of Nanomediated Drug Delivery Systems of Taxanes for the Treatment of Cancer1178-2013https://doaj.org/article/da2b094e68184f01a02aca51e7ee3acb2020-10-01T00:00:00Zhttps://www.dovepress.com/recent-clinical-developments-of-nanomediated-drug-delivery-systems-of--peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Ruben AG van Eerden,1 Ron HJ Mathijssen,1 Stijn LW Koolen1,2 1Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands; 2Department of Hospital Pharmacy, Erasmus MC University Medical Center, Rotterdam, the NetherlandsCorrespondence: Ruben AG van EerdenDepartment of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, PO Box 2040, Rotterdam 3000 CA, the NetherlandsTel +31 10 7039640Email r.vaneerden@erasmusmc.nlAbstract: Conventional taxanes are used as cornerstone of the chemotherapeutical treatment for a variety of malignancies. Nevertheless, a large proportion of patients do not benefit from their treatment while they do suffer from severe adverse events related to the solvent or to the active compound. Cremophor EL and polysorbate 80 free formulations, conjugates, oral formulations and different types of drug delivery systems are some examples of the several attempts to improve the treatment with taxanes. In this review article, we discuss recent clinical developments of nanomediated drug delivery systems of taxanes for the treatment of cancer. Targeting mechanisms of drug delivery systems and characteristics of the most commonly used taxane-containing drug delivery systems in the clinical setting will be discussed in this review.Keywords: nanomedicine, nanoparticle, drug delivery systems, taxane, cancervan Eerden RAGMathijssen RHJKoolen SLWDove Medical Pressarticlenanomedicinenanoparticledrug delivery systemstaxanecancerMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 15, Pp 8151-8166 (2020)
institution DOAJ
collection DOAJ
language EN
topic nanomedicine
nanoparticle
drug delivery systems
taxane
cancer
Medicine (General)
R5-920
spellingShingle nanomedicine
nanoparticle
drug delivery systems
taxane
cancer
Medicine (General)
R5-920
van Eerden RAG
Mathijssen RHJ
Koolen SLW
Recent Clinical Developments of Nanomediated Drug Delivery Systems of Taxanes for the Treatment of Cancer
description Ruben AG van Eerden,1 Ron HJ Mathijssen,1 Stijn LW Koolen1,2 1Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands; 2Department of Hospital Pharmacy, Erasmus MC University Medical Center, Rotterdam, the NetherlandsCorrespondence: Ruben AG van EerdenDepartment of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, PO Box 2040, Rotterdam 3000 CA, the NetherlandsTel +31 10 7039640Email r.vaneerden@erasmusmc.nlAbstract: Conventional taxanes are used as cornerstone of the chemotherapeutical treatment for a variety of malignancies. Nevertheless, a large proportion of patients do not benefit from their treatment while they do suffer from severe adverse events related to the solvent or to the active compound. Cremophor EL and polysorbate 80 free formulations, conjugates, oral formulations and different types of drug delivery systems are some examples of the several attempts to improve the treatment with taxanes. In this review article, we discuss recent clinical developments of nanomediated drug delivery systems of taxanes for the treatment of cancer. Targeting mechanisms of drug delivery systems and characteristics of the most commonly used taxane-containing drug delivery systems in the clinical setting will be discussed in this review.Keywords: nanomedicine, nanoparticle, drug delivery systems, taxane, cancer
format article
author van Eerden RAG
Mathijssen RHJ
Koolen SLW
author_facet van Eerden RAG
Mathijssen RHJ
Koolen SLW
author_sort van Eerden RAG
title Recent Clinical Developments of Nanomediated Drug Delivery Systems of Taxanes for the Treatment of Cancer
title_short Recent Clinical Developments of Nanomediated Drug Delivery Systems of Taxanes for the Treatment of Cancer
title_full Recent Clinical Developments of Nanomediated Drug Delivery Systems of Taxanes for the Treatment of Cancer
title_fullStr Recent Clinical Developments of Nanomediated Drug Delivery Systems of Taxanes for the Treatment of Cancer
title_full_unstemmed Recent Clinical Developments of Nanomediated Drug Delivery Systems of Taxanes for the Treatment of Cancer
title_sort recent clinical developments of nanomediated drug delivery systems of taxanes for the treatment of cancer
publisher Dove Medical Press
publishDate 2020
url https://doaj.org/article/da2b094e68184f01a02aca51e7ee3acb
work_keys_str_mv AT vaneerdenrag recentclinicaldevelopmentsofnanomediateddrugdeliverysystemsoftaxanesforthetreatmentofcancer
AT mathijssenrhj recentclinicaldevelopmentsofnanomediateddrugdeliverysystemsoftaxanesforthetreatmentofcancer
AT koolenslw recentclinicaldevelopmentsofnanomediateddrugdeliverysystemsoftaxanesforthetreatmentofcancer
_version_ 1718387234769469440